BPaMZ and BPaL: Two new drug therapies might cure every form of TB
1302  

BPaMZ and BPaL: Two new drug therapies might cure every form of TB

Tuberculosis, the world’s leading infectious killer, may have finally met its match. Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat. “We will have something to offer every single patient,” says Mel Spigelman, president ...

February 20, 2017
EATG  News  

Medicines Patent Pool announces first licence for TB treatment

In an effort to improve the international response to combatting multidrug-resistant TB, MPP and Johns Hopkins University sign licensing agreement for investigational treatment sutezolid Geneva, 25 January 2017 — The Medicines Patent Pool today announced that it has signed a licence with Johns Hopkins University ...

January 26, 2017
EATG  EATG  News  News  

Uzbekistan: Pioneering clinical trial for drug-resistant TB starts

A pioneering new clinical trial aiming to find a radically improved course of treatment for drug-resistant tuberculosis (TB) began on 17th January 2017, when the first patient took the first pill in Uzbekistan. The phase II/III trial, called TB PRACTECAL, aims to find a treatment regime ...

January 24, 2017
EATG  News  

Cleverly designed TB vaccine shows promise in mice

Washington, DC – January 13, 2017 – A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the ...

January 16, 2017
EATG  News  

Unknown unknowns: poverty and tuberculosis in Romania

Mircea, a former miner in his fifties, spent the last four years of his life succumbing to Extensively Drug Resistant Tuberculosis (XDR-TB) at the Pines Tuberculosis Sanatorium, which is located high on a mountain. After seven years with this otherwise curable illness, his family wanted ...

November 20, 2016
EATG  News